Skip to main navigation Skip to main content Skip to page footer

What documentation is required for IQ/OQ/PQ for pharmaceutical mixing plants?

Qualifying pharmaceutical mixing plants requires complete, traceable and approved documentation. It demonstrates that the plant is planned, constructed, installed, tested and operated in accordance with the defined requirements. It must also be shown that the mixing plant delivers reproducible results within its intended field of use.

The required scope depends on risk. Decisive factors include, among others, the product and dosage form, the impact on critical quality attributes, the degree of automation, the cleaning strategy, data integrity and regulatory requirements. The structure is often based on EU GMP Annex 15 for qualification and validation and on EU GMP Annex 11 for computerised systems.

Cross-cutting documents

The starting point is the User Requirement Specification. It describes all requirements for the mixing plant, for example product-contact materials, surface quality, volume, fill-level ranges, mixing time, homogeneity, temperature, pressure, vacuum, cleanability, containment, explosion protection, interfaces, control system and electronic data capture.

A validation master plan or project-specific qualification plan defines strategy, scope, roles, responsibilities, approvals and timelines. A risk analysis identifies critical functions, components and process parameters. Suitable methods include, for example, failure mode and effects analysis, HACCP or risk-based assessments under ICH Q9.

Functional and design specifications are additionally prepared. The Design Qualification documents that the plant design meets the requirements from the User Requirement Specification. A traceability matrix links requirements, risks, design, test cases, results and approvals.

Factory Acceptance Tests and Site Acceptance Tests can be used for qualification if they are planned in advance, documented with clear acceptance criteria and assessed on a risk basis. The precondition is that transport and installation do not materially affect the functions already demonstrated.

Documentation for the IQ

The Installation Qualification confirms that the mixing plant has been installed in accordance with the approved drawings, specifications and manufacturer's data. The IQ protocol contains test points, acceptance criteria, results, deviations and approvals.

Typical evidence includes as-built drawings, layout plans, P&ID diagrams, electrical circuit diagrams, connection overviews, parts lists and component identification. For product-contact parts, material certificates, surface specifications, roughness records, passivation evidence and welding documentation are usually required.

The IQ also includes evidence relating to the supply systems, such as electricity, compressed air, pure gases, steam, heating and cooling media, vacuum and purified water. Calibration certificates must be available for all quality-relevant measuring points, for example for temperature, pressure, vacuum, rotational speed, torque, time, flow and level. EU GMP Annex 15 names, among other things, installation, supply media, instrumentation, manufacturer documentation, calibration and materials as elements of the Installation Qualification.

For automated mixing plants, the IQ additionally covers the version status of the PLC, the operator interface, recipe management, interfaces and configurations. User rights, data backup, recoverability and change management must be assessed for GMP-relevant systems.

Documentation for the OQ

The Operational Qualification demonstrates that the plant operates safely and reproducibly within the defined operating range. The OQ protocol describes test cases, test steps, target values, limit values and acceptance criteria.

Tests cover, for example, the mixing tool, rotational speed, direction of rotation, torque, temperature, pressure, vacuum, dosing, valves, discharge and relevant safety devices. Alarms, interlocks, emergency-stop functions and protective functions must also be tested. The tests should cover the upper and lower operating limits as well as justified worst-case conditions.

For the control system, automatic and manual operation, recipe sequences, operator messages, user roles and interfaces are tested. For GMP-relevant electronic data, audit trails must be provided for risk-relevant changes and deletions. They must make traceable who made which change and when.

For plants with CIP or SIP, the OQ also includes verification of the cleaning or sterilisation programmes. This covers time, temperature, pressure, flow, concentration and the correct actuation of the components. A riboflavin test can make the wetting of internal surfaces visible, but it does not replace product-specific cleaning validation.

Documentation for the PQ

The Performance Qualification demonstrates that the plant reliably delivers specification-compliant results with the intended product under routine conditions. The PQ plan describes the product, recipe, process parameters, fill quantities, sampling, analytical methods and acceptance criteria.

For mixing plants, homogeneity is usually the central focus. Samples are taken at defined locations and times and examined for relevant quality parameters. These can include active-ingredient content, content uniformity, moisture, particle size distribution, density, flowability, viscosity or microbiological characteristics. Minimum and maximum fill quantities and critical mixing times are also frequently considered.

There is no generally mandated fixed number of successful PQ batches under regulation. Three consecutive batches are a widespread practical approach, but must be justified by process knowledge and a documented risk assessment. The FDA follows a lifecycle approach and does not prescribe a fixed number of validation batches.

Cleaning validation can also form part of the PQ. It covers limit values, sampling points and suitable analytical methods for product residues, cleaning agents and, where relevant, microbiological contamination. The PQ final report evaluates the results, deviations, corrective actions and the fulfilment of all acceptance criteria.

Ongoing documentation

The qualified state must be maintained through maintenance, inspection, calibration, cleaning, training and change management. Standard operating procedures govern operation, cleaning, sampling, fault management, data review and maintenance.

Changes to the mixing tool, seals, measuring points, control software, recipes, cleaning programmes or operating limits must be assessed through change control. Depending on the risk, partial tests, requalification or a renewed Performance Qualification may be necessary. Documented training records for operation, maintenance and quality assurance are likewise required on an ongoing basis.

How amixon® supports FAT and SAT and the qualification of pharmaceutical mixing plants

amixon® develops customer-specific mixing plants, agglomerators, vacuum mixer dryers and synthesis reactors on the basis of the operator's User Requirement Specification. Every plant is manufactured at the Paderborn works. This makes it possible to link requirements, design, manufacturing and technical documentation with one another throughout the entire project.

Depending on the agreed scope of supply, amixon® provides qualification-relevant documentation. This includes, for example, technical drawings, parts lists, material certificates for product-contact components, surface specifications, welding documentation, operating instructions, maintenance documentation and test protocols. The operator can use these documents for its own traceability matrix as well as for IQ and OQ documentation.

amixon® supports the Design Qualification, Installation Qualification and Operational Qualification. Documentation and execution can be aligned with the requirements of EU GMP and FDA 21 CFR Part 11. The mixing plant is thereby integrated along the operator's validation concept, from the User Requirement Specification through to commissioning. The specific responsibility for approvals, GMP assessment and the scope of validation remains with the operator.

The Factory Acceptance Test takes place on the fully assembled apparatus at the Paderborn works. It is based on the agreed test points from the User Requirement Specification, the technical specifications and the agreed test plan. Mechanical functions, control sequences, safety functions and project-specific requirements can be tested and documented in the process.

After installation at the operator's site, amixon® can accompany the assembly and the Site Acceptance Test. The SAT checks whether the plant is correctly installed under the real conditions at the site of use and fulfils the agreed functions. Documented results from the FAT and SAT can feed into the operator's IQ and OQ as technical evidence. The Performance Qualification with the later product and the release of the routine process remain the operator's responsibility.

To prepare the Performance Qualification, amixon® offers pilot-plant trials with the original product. More than thirty test units in various sizes are available at the amixon® pilot plant in Paderborn. amixon® additionally operates pilot plants in Germany, the United States, China, Japan, India, Thailand and South Korea. There, mixing quality, product protection, energy input, cleanability and reproducibility, among other factors, can be assessed under realistic fill levels and the intended temperature and pressure conditions. The documented results can provide a well-founded starting basis for process parameters, scale-up and PQ planning.

The hygienic design supports the qualifiability of the mixing plant. amixon® mixers can be configured with a top-mounted mixing tool, product-contact areas designed with minimal joints, and large Clever-Cut® inspection doors. The inspection doors provide access to the mixing chamber and support visual inspection as well as cleaning validation. Depending on the design, WIP- and CIP-compatible cleaning concepts and applications in line with GMP, EHEDG, FDA and 3-A Sanitary Standards are possible.

For sterile or particularly demanding pharmaceutical applications, amixon® can incorporate the requirements for hygienic design, cleaning and, where relevant, sterilisation into the project-specific design. The specific suitability for a product, a cleaning method or a validation strategy is assessed on the basis of the User Requirement Specification, the risk analysis and the agreed acceptance criteria.

In addition to the documentation and the technical tests, amixon® can conduct training for operating and maintenance personnel. This can cover the safe operation, recipe sequences, cleaning, maintenance, inspection and troubleshooting of the delivered plant. This gives operators a foundation tailored to the specific mixing plant for qualified and traceable operation.